Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuda Lin

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Heliyon|June 22, 2023
Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics dataChong Shen, Chong Fu, Yong Suo, et al.
Heliyon|April 1, 2024
The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysisChong Shen, Tong Wang, Kai Li, et al.
Molecular Cancer|March 20, 2024
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trialJunlong Wu, Yuda Lin, Kaiwei Yang, et al.
Frontiers in Oncology|October 27, 2022
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancerChong Shen, Zhi Li, Yinglang Zhang, et al.
Cancer|June 24, 2026
Magnetic resonance imaging radiomic phenotypes stratify response and define immune states in very high-risk, nonmuscle-invasive bladder cancer treated with tislelizumab plus nanoparticle albumin-bound paclitaxelShiwang Huang, Kaipeng Jia, Shan Liang, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Heliyon|June 22, 2023
Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics dataChong Shen, Chong Fu, Yong Suo, et al.
Heliyon|April 1, 2024
The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysisChong Shen, Tong Wang, Kai Li, et al.
Molecular Cancer|March 20, 2024
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trialJunlong Wu, Yuda Lin, Kaiwei Yang, et al.
Frontiers in Oncology|October 27, 2022
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancerChong Shen, Zhi Li, Yinglang Zhang, et al.
Cancer|June 24, 2026
Magnetic resonance imaging radiomic phenotypes stratify response and define immune states in very high-risk, nonmuscle-invasive bladder cancer treated with tislelizumab plus nanoparticle albumin-bound paclitaxelShiwang Huang, Kaipeng Jia, Shan Liang, et al.
Pageof 3